Share Price and Basic Stock Data
Last Updated: November 8, 2025, 3:55 am
| PEG Ratio | 0.51 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Shreeoswal Seeds & Chemicals Ltd operates in the seeds, tissue culture, and biotechnology industry, with a current market capitalization of ₹141 Cr. The company’s stock price stood at ₹15.4. Revenue trends reveal fluctuations, with total sales reported at ₹272 Cr for the fiscal year ending March 2023, a decline to ₹269 Cr in March 2024, and an estimated ₹246 Cr for March 2025. Quarterly sales data shows a peak in June 2022 at ₹126.74 Cr, followed by a significant drop to ₹26.27 Cr in March 2023. However, sales rebounded to ₹83.32 Cr in June 2023, indicating potential recovery. The trailing twelve months (TTM) sales reported at ₹267 Cr suggest a slight decrease compared to the previous fiscal year but remain relatively stable. Overall, while the company has experienced volatility in revenue, the recent quarterly performance indicates a possible upward trajectory.
Profitability and Efficiency Metrics
Profitability metrics for Shreeoswal Seeds & Chemicals Ltd reflect challenges and opportunities. The operating profit margin (OPM) reported at 11.47% for the latest quarter shows an improvement compared to previous periods, where it fluctuated significantly, including negative margins in several quarters. The net profit for the fiscal year 2025 is projected at ₹4 Cr, demonstrating a recovery from a loss of ₹4 Cr in March 2024. Return on equity (ROE) stood at 8.41%, while return on capital employed (ROCE) was reported at 9.88%, both of which are relatively low compared to industry standards, indicating room for improvement in capital utilization. The cash conversion cycle (CCC) of 462 days highlights inefficiencies in inventory management and receivables, which could impact liquidity and operational efficiency. Overall, while profitability shows signs of recovery, the company must address efficiency issues to enhance margins further.
Balance Sheet Strength and Financial Ratios
The balance sheet of Shreeoswal Seeds & Chemicals Ltd presents a mixed picture. As of the latest reporting period, total borrowings stood at ₹42 Cr, reflecting a manageable debt level given the total equity capital of ₹18 Cr. The debt-to-equity ratio of 0.95 indicates moderate leverage, which could pose risks if revenue volatility persists. The company’s reserves have increased to ₹25 Cr, providing a buffer for financial stability. Key financial ratios reveal an interest coverage ratio (ICR) of 2.31x, suggesting adequate ability to meet interest obligations, although this is lower than optimal levels. The price-to-book value ratio (P/BV) stood at 2.43x, indicating a premium over book value, which may reflect investor confidence but also suggests that the stock could be overvalued compared to peers. Overall, while the balance sheet shows resilience, the company needs to improve its financial ratios to strengthen its position.
Shareholding Pattern and Investor Confidence
Shreeoswal Seeds & Chemicals Ltd has a concentrated shareholding structure, with promoters holding 66.63% of the total shares, reflecting strong control over the company. The public shareholding stands at 33.37%, which has gradually increased from 29.89% in September 2022 to the current level, indicating growing retail interest. Foreign institutional investors (FIIs) have remained absent, with 0% holding reported across various quarters, which may reflect a lack of confidence in the company’s growth prospects. The number of shareholders surged from 181 in September 2022 to 25,784 in September 2025, showcasing increasing investor interest and confidence in the company’s potential. This rising trend in public participation could be a positive indicator for future liquidity and market perception. However, the absence of institutional backing may limit broader market appeal and confidence.
Outlook, Risks, and Final Insight
The outlook for Shreeoswal Seeds & Chemicals Ltd hinges on its ability to stabilize revenues and improve operational efficiencies. The company faces several risks, including fluctuating sales, high CCC, and reliance on a concentrated shareholder base, which may limit strategic flexibility. Strengths include a strong promoter holding, an improving OPM, and manageable debt levels. The company must focus on improving inventory management and enhancing capital efficiency to boost profitability and return ratios. If Shreeoswal can execute on these fronts, it may position itself favorably in the competitive seeds and biotechnology market. Conversely, failure to address these issues could hinder growth and affect investor sentiment negatively. Overall, the company’s performance in the coming quarters will be crucial in determining its long-term viability and market positioning.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Shreeoswal Seeds & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech Ltd | 9.43 Cr. | 30.9 | 108/27.2 | 94.3 | 12.8 | 0.00 % | 11.8 % | 9.68 % | 10.0 |
| Genesis IBRC India Ltd | 231 Cr. | 178 | 178/16.6 | 66.4 | 6.56 | 0.00 % | 51.6 % | 51.6 % | 10.0 |
| Shreeoswal Seeds & Chemicals Ltd | 138 Cr. | 15.1 | 23.7/10.7 | 10.2 | 4.78 | 0.00 % | 9.88 % | 8.41 % | 2.00 |
| Nath Bio-Genes (India) Ltd | 325 Cr. | 171 | 239/138 | 7.09 | 341 | 1.17 % | 7.35 % | 6.77 % | 10.0 |
| Continental Seeds and Chemicals Ltd | 23.6 Cr. | 21.4 | 47.5/20.8 | 39.9 | 25.8 | 0.00 % | 4.24 % | 2.87 % | 10.0 |
| Industry Average | 231.33 Cr | 83.28 | 43.58 | 78.19 | 0.23% | 16.97% | 15.87% | 8.40 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 126.74 | 32.69 | 86.62 | 26.27 | 83.32 | 65.55 | 76.74 | 43.42 | 76.95 | 67.69 | 75.42 | 25.85 | 97.95 |
| Expenses | 118.85 | 32.82 | 82.92 | 25.82 | 78.90 | 63.15 | 77.92 | 48.05 | 78.98 | 66.16 | 67.30 | 23.91 | 86.72 |
| Operating Profit | 7.89 | -0.13 | 3.70 | 0.45 | 4.42 | 2.40 | -1.18 | -4.63 | -2.03 | 1.53 | 8.12 | 1.94 | 11.23 |
| OPM % | 6.23% | -0.40% | 4.27% | 1.71% | 5.30% | 3.66% | -1.54% | -10.66% | -2.64% | 2.26% | 10.77% | 7.50% | 11.47% |
| Other Income | 0.02 | 0.02 | 0.02 | 0.07 | 0.00 | 0.01 | 0.00 | 0.09 | 0.01 | 0.00 | 0.05 | 0.24 | 0.07 |
| Interest | 0.82 | 0.84 | 1.51 | 0.53 | 1.49 | 1.38 | 1.54 | 1.57 | 1.45 | 0.95 | 0.75 | 1.12 | 1.05 |
| Depreciation | 0.10 | 0.10 | 0.11 | 0.12 | 0.12 | 0.14 | 0.17 | 0.08 | 0.13 | 0.13 | 0.12 | 0.12 | 0.15 |
| Profit before tax | 6.99 | -1.05 | 2.10 | -0.13 | 2.81 | 0.89 | -2.89 | -6.19 | -3.60 | 0.45 | 7.30 | 0.94 | 10.10 |
| Tax % | 20.03% | 23.81% | 20.95% | 76.92% | 28.11% | 28.09% | 14.88% | -43.30% | -24.44% | 31.11% | 26.44% | 40.43% | 27.92% |
| Net Profit | 5.58 | -1.30 | 1.66 | -0.23 | 2.03 | 0.64 | -3.32 | -3.51 | -2.72 | 0.32 | 5.37 | 0.55 | 7.28 |
| EPS in Rs | 0.61 | -0.14 | 0.18 | -0.03 | 0.22 | 0.07 | -0.36 | -0.38 | -0.30 | 0.03 | 0.59 | 0.06 | 0.80 |
Last Updated: August 20, 2025, 3:40 am
Below is a detailed analysis of the quarterly data for Shreeoswal Seeds & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 97.95 Cr.. The value appears strong and on an upward trend. It has increased from 25.85 Cr. (Mar 2025) to 97.95 Cr., marking an increase of 72.10 Cr..
- For Expenses, as of Jun 2025, the value is 86.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.91 Cr. (Mar 2025) to 86.72 Cr., marking an increase of 62.81 Cr..
- For Operating Profit, as of Jun 2025, the value is 11.23 Cr.. The value appears strong and on an upward trend. It has increased from 1.94 Cr. (Mar 2025) to 11.23 Cr., marking an increase of 9.29 Cr..
- For OPM %, as of Jun 2025, the value is 11.47%. The value appears strong and on an upward trend. It has increased from 7.50% (Mar 2025) to 11.47%, marking an increase of 3.97%.
- For Other Income, as of Jun 2025, the value is 0.07 Cr.. The value appears to be declining and may need further review. It has decreased from 0.24 Cr. (Mar 2025) to 0.07 Cr., marking a decrease of 0.17 Cr..
- For Interest, as of Jun 2025, the value is 1.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.12 Cr. (Mar 2025) to 1.05 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.12 Cr. (Mar 2025) to 0.15 Cr., marking an increase of 0.03 Cr..
- For Profit before tax, as of Jun 2025, the value is 10.10 Cr.. The value appears strong and on an upward trend. It has increased from 0.94 Cr. (Mar 2025) to 10.10 Cr., marking an increase of 9.16 Cr..
- For Tax %, as of Jun 2025, the value is 27.92%. The value appears to be improving (decreasing) as expected. It has decreased from 40.43% (Mar 2025) to 27.92%, marking a decrease of 12.51%.
- For Net Profit, as of Jun 2025, the value is 7.28 Cr.. The value appears strong and on an upward trend. It has increased from 0.55 Cr. (Mar 2025) to 7.28 Cr., marking an increase of 6.73 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.80. The value appears strong and on an upward trend. It has increased from 0.06 (Mar 2025) to 0.80, marking an increase of 0.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:27 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 18 | 126 | 117 | 161 | 241 | 272 | 269 | 246 | 267 |
| Expenses | 16 | 120 | 110 | 154 | 230 | 260 | 268 | 236 | 244 |
| Operating Profit | 2 | 6 | 7 | 8 | 10 | 12 | 1 | 10 | 23 |
| OPM % | 10% | 5% | 6% | 5% | 4% | 4% | 0% | 4% | 9% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 | 2 | 3 | 4 | 6 | 4 | 4 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Profit before tax | 1 | 4 | 4 | 5 | 8 | 8 | -5 | 5 | 19 |
| Tax % | 20% | 26% | 28% | 28% | 28% | 28% | -23% | 31% | |
| Net Profit | 1 | 3 | 3 | 4 | 5 | 6 | -4 | 4 | 14 |
| EPS in Rs | 0.18 | 0.31 | 0.33 | 0.40 | 0.59 | 0.62 | -0.45 | 0.39 | 1.48 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | 0.00% | 33.33% | 25.00% | 20.00% | -166.67% | 200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -200.00% | 33.33% | -8.33% | -5.00% | -186.67% | 366.67% |
Shreeoswal Seeds & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 1% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -13% |
| TTM: | 252% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 0% |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 7% |
| 3 Years: | 4% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:31 pm
Balance Sheet
Last Updated: June 16, 2025, 11:21 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 15 | 15 | 15 | 15 | 15 | 18 | 18 |
| Reserves | 1 | 11 | 14 | 18 | 23 | 29 | 22 | 25 |
| Borrowings | 25 | 24 | 30 | 43 | 42 | 41 | 64 | 42 |
| Other Liabilities | 15 | 11 | 7 | 16 | 40 | 43 | 20 | 19 |
| Total Liabilities | 52 | 61 | 66 | 93 | 120 | 128 | 124 | 105 |
| Fixed Assets | 2 | 2 | 4 | 4 | 4 | 4 | 7 | 6 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 50 | 59 | 63 | 89 | 115 | 122 | 115 | 96 |
| Total Assets | 52 | 61 | 66 | 93 | 120 | 128 | 124 | 105 |
Below is a detailed analysis of the balance sheet data for Shreeoswal Seeds & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
- For Reserves, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Mar 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 64.00 Cr. (Mar 2024) to 42.00 Cr., marking a decrease of 22.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 19.00 Cr.. The value appears to be improving (decreasing). It has decreased from 20.00 Cr. (Mar 2024) to 19.00 Cr., marking a decrease of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 105.00 Cr.. The value appears to be improving (decreasing). It has decreased from 124.00 Cr. (Mar 2024) to 105.00 Cr., marking a decrease of 19.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 6.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 96.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Mar 2024) to 96.00 Cr., marking a decrease of 19.00 Cr..
- For Total Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Mar 2024) to 105.00 Cr., marking a decrease of 19.00 Cr..
However, the Borrowings (42.00 Cr.) are higher than the Reserves (25.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -23.00 | -18.00 | -23.00 | -35.00 | -32.00 | -29.00 | -63.00 | -32.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 227 | 32 | 39 | 14 | 29 | 11 | 24 | 19 |
| Inventory Days | 790 | 134 | 147 | 190 | 144 | 147 | 1,540 | 474 |
| Days Payable | 334 | 28 | 3 | 4 | 5 | 4 | 53 | 30 |
| Cash Conversion Cycle | 683 | 137 | 182 | 201 | 168 | 154 | 1,511 | 462 |
| Working Capital Days | 211 | 59 | 74 | 75 | 56 | 47 | 36 | 49 |
| ROCE % | 14% | 12% | 11% | 13% | 14% | 1% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.39 | -0.45 | 0.62 | 3.57 | 2.39 |
| Diluted EPS (Rs.) | 0.39 | -0.45 | 0.62 | 3.57 | 2.39 |
| Cash EPS (Rs.) | 0.44 | -0.39 | 4.03 | 3.82 | 2.59 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 4.78 | 4.40 | 29.10 | 25.38 | 21.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 4.78 | 4.40 | 29.10 | 25.38 | 21.81 |
| Revenue From Operations / Share (Rs.) | 26.88 | 29.41 | 178.64 | 157.77 | 105.75 |
| PBDIT / Share (Rs.) | 1.08 | 0.12 | 7.89 | 6.94 | 5.11 |
| PBIT / Share (Rs.) | 1.02 | 0.06 | 7.61 | 6.68 | 4.92 |
| PBT / Share (Rs.) | 0.55 | -0.58 | 5.18 | 4.97 | 3.32 |
| Net Profit / Share (Rs.) | 0.38 | -0.45 | 3.74 | 3.56 | 2.39 |
| NP After MI And SOA / Share (Rs.) | 0.38 | -0.45 | 3.74 | 3.56 | 2.39 |
| PBDIT Margin (%) | 4.01 | 0.41 | 4.41 | 4.39 | 4.83 |
| PBIT Margin (%) | 3.81 | 0.22 | 4.26 | 4.23 | 4.64 |
| PBT Margin (%) | 2.07 | -1.99 | 2.89 | 3.14 | 3.13 |
| Net Profit Margin (%) | 1.43 | -1.54 | 2.09 | 2.25 | 2.26 |
| NP After MI And SOA Margin (%) | 1.43 | -1.54 | 2.09 | 2.25 | 2.26 |
| Return on Networth / Equity (%) | 8.07 | -10.34 | 12.86 | 14.04 | 10.97 |
| Return on Capital Employeed (%) | 20.39 | 1.44 | 24.85 | 23.49 | 19.23 |
| Return On Assets (%) | 3.35 | -3.35 | 4.45 | 4.53 | 3.93 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.03 | 0.11 | 0.16 |
| Total Debt / Equity (X) | 0.95 | 1.59 | 0.92 | 1.07 | 1.30 |
| Asset Turnover Ratio (%) | 2.15 | 2.13 | 2.20 | 1.08 | 1.09 |
| Current Ratio (X) | 1.56 | 1.35 | 1.49 | 1.50 | 1.63 |
| Quick Ratio (X) | 0.46 | 0.35 | 0.23 | 0.33 | 0.24 |
| Inventory Turnover Ratio (X) | 3.32 | 2.71 | 2.99 | 1.45 | 2.13 |
| Interest Coverage Ratio (X) | 2.31 | 0.18 | 3.25 | 4.05 | 3.20 |
| Interest Coverage Ratio (Post Tax) (X) | 1.83 | 0.30 | 2.54 | 3.08 | 2.50 |
| Enterprise Value (Cr.) | 148.16 | 327.05 | 531.16 | 126.80 | 89.37 |
| EV / Net Operating Revenue (X) | 0.60 | 1.22 | 1.95 | 0.52 | 0.55 |
| EV / EBITDA (X) | 15.01 | 293.97 | 44.13 | 11.99 | 11.46 |
| MarketCap / Net Operating Revenue (X) | 0.43 | 0.98 | 1.82 | 0.36 | 0.29 |
| Price / BV (X) | 2.43 | 6.62 | 11.16 | 2.25 | 1.41 |
| Price / Net Operating Revenue (X) | 0.43 | 0.98 | 1.82 | 0.36 | 0.29 |
| EarningsYield | 0.03 | -0.01 | 0.01 | 0.06 | 0.07 |
After reviewing the key financial ratios for Shreeoswal Seeds & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -0.45 (Mar 24) to 0.39, marking an increase of 0.84.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -0.45 (Mar 24) to 0.39, marking an increase of 0.84.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 3. It has increased from -0.39 (Mar 24) to 0.44, marking an increase of 0.83.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.78. It has increased from 4.40 (Mar 24) to 4.78, marking an increase of 0.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.78. It has increased from 4.40 (Mar 24) to 4.78, marking an increase of 0.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 26.88. It has decreased from 29.41 (Mar 24) to 26.88, marking a decrease of 2.53.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has increased from 0.12 (Mar 24) to 1.08, marking an increase of 0.96.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.02. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 1.02, marking an increase of 0.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.55. This value is within the healthy range. It has increased from -0.58 (Mar 24) to 0.55, marking an increase of 1.13.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has increased from -0.45 (Mar 24) to 0.38, marking an increase of 0.83.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has increased from -0.45 (Mar 24) to 0.38, marking an increase of 0.83.
- For PBDIT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has increased from 0.41 (Mar 24) to 4.01, marking an increase of 3.60.
- For PBIT Margin (%), as of Mar 25, the value is 3.81. This value is below the healthy minimum of 10. It has increased from 0.22 (Mar 24) to 3.81, marking an increase of 3.59.
- For PBT Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 10. It has increased from -1.99 (Mar 24) to 2.07, marking an increase of 4.06.
- For Net Profit Margin (%), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 5. It has increased from -1.54 (Mar 24) to 1.43, marking an increase of 2.97.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 8. It has increased from -1.54 (Mar 24) to 1.43, marking an increase of 2.97.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.07. This value is below the healthy minimum of 15. It has increased from -10.34 (Mar 24) to 8.07, marking an increase of 18.41.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 20.39, marking an increase of 18.95.
- For Return On Assets (%), as of Mar 25, the value is 3.35. This value is below the healthy minimum of 5. It has increased from -3.35 (Mar 24) to 3.35, marking an increase of 6.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.95. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 0.95, marking a decrease of 0.64.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.15. It has increased from 2.13 (Mar 24) to 2.15, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 1.56, marking an increase of 0.21.
- For Quick Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 24) to 0.46, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.32. This value is below the healthy minimum of 4. It has increased from 2.71 (Mar 24) to 3.32, marking an increase of 0.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 3. It has increased from 0.18 (Mar 24) to 2.31, marking an increase of 2.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 3. It has increased from 0.30 (Mar 24) to 1.83, marking an increase of 1.53.
- For Enterprise Value (Cr.), as of Mar 25, the value is 148.16. It has decreased from 327.05 (Mar 24) to 148.16, marking a decrease of 178.89.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 1.22 (Mar 24) to 0.60, marking a decrease of 0.62.
- For EV / EBITDA (X), as of Mar 25, the value is 15.01. This value exceeds the healthy maximum of 15. It has decreased from 293.97 (Mar 24) to 15.01, marking a decrease of 278.96.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.43, marking a decrease of 0.55.
- For Price / BV (X), as of Mar 25, the value is 2.43. This value is within the healthy range. It has decreased from 6.62 (Mar 24) to 2.43, marking a decrease of 4.19.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.43, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.03, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Shreeoswal Seeds & Chemicals Ltd:
- Net Profit Margin: 1.43%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.39% (Industry Average ROCE: 16.97%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.07% (Industry Average ROE: 15.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.83
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.2 (Industry average Stock P/E: 43.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.95
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.43%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Seeds/Tissue Culture/Bio Technology | Oswal House, Neemuch Madhya Pradesh 458441 | oswalgroups2002@gmail.com http://www.oswalseeds.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Kumar Baigani | Chairman & Managing Director |
| Mr. Anil Kumar Nahata | WholeTime Director & CEO |
| Mrs. Kiran Devi Begani | Non Exe.Non Ind.Director |
| Mr. Deepak Kothari | Ind. Non-Executive Director |
| Mr. Yash Wardhan Jain | Ind. Non-Executive Director |
| Mr. Sanjay Chordiya | Ind. Non-Executive Director |
| Mr. Umesh Kumar Sharma | Ind. Non-Executive Director |
| Mrs. Padma Nahta | Non Exe.Non Ind.Director |
| Mrs. Anjali Bamboria | Ind. Non-Executive Woman Director |
| Mr. Kanhaiya Lal Kumawat | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Shreeoswal Seeds & Chemicals Ltd?
Shreeoswal Seeds & Chemicals Ltd's intrinsic value (as of 09 November 2025) is 3.35 which is 77.81% lower the current market price of 15.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 138 Cr. market cap, FY2025-2026 high/low of 23.7/10.7, reserves of ₹25 Cr, and liabilities of 105 Cr.
What is the Market Cap of Shreeoswal Seeds & Chemicals Ltd?
The Market Cap of Shreeoswal Seeds & Chemicals Ltd is 138 Cr..
What is the current Stock Price of Shreeoswal Seeds & Chemicals Ltd as on 09 November 2025?
The current stock price of Shreeoswal Seeds & Chemicals Ltd as on 09 November 2025 is 15.1.
What is the High / Low of Shreeoswal Seeds & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Shreeoswal Seeds & Chemicals Ltd stocks is 23.7/10.7.
What is the Stock P/E of Shreeoswal Seeds & Chemicals Ltd?
The Stock P/E of Shreeoswal Seeds & Chemicals Ltd is 10.2.
What is the Book Value of Shreeoswal Seeds & Chemicals Ltd?
The Book Value of Shreeoswal Seeds & Chemicals Ltd is 4.78.
What is the Dividend Yield of Shreeoswal Seeds & Chemicals Ltd?
The Dividend Yield of Shreeoswal Seeds & Chemicals Ltd is 0.00 %.
What is the ROCE of Shreeoswal Seeds & Chemicals Ltd?
The ROCE of Shreeoswal Seeds & Chemicals Ltd is 9.88 %.
What is the ROE of Shreeoswal Seeds & Chemicals Ltd?
The ROE of Shreeoswal Seeds & Chemicals Ltd is 8.41 %.
What is the Face Value of Shreeoswal Seeds & Chemicals Ltd?
The Face Value of Shreeoswal Seeds & Chemicals Ltd is 2.00.